Corpse flower countdown: Stink Floyd nears bloom
Stink Floyd, the corpse flower at Iowa State's Reiman Gardens, is this close to unleashing its signature stench.
The big picture: When? "That's the million-dollar question!" Reiman spokesperson Andrew Gogerty tells Axios.
"We know it's close, but that's all we know."
The intrigue: Corpse flowers, endangered plants originating from Sumatra, are the drama queens of the plant world — taking up to a decade to bloom for the first time and remaining unpredictable.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
4 days ago
- Axios
AI pioneer Bengio launches $30M nonprofit to rethink safety
Machine learning pioneer Yoshua Bengio is launching a new nonprofit lab backed by roughly $30 million in funding to make AI systems act less like humans. Why it matters: While the move bucks a trend toward AI that acts independently, Bengio and others argue the current approach risks creating systems that may pursue their own self-preservation at the expense of humanity. "We've been getting inspiration from humans as the template for building intelligent machines, but that's crazy, right?" Bengio said in an interview. "If we continue on this path, that means we're going to be creating entities — like us — that don't want to die, and that may be smarter than us and that we're not sure if they're going to behave according to our norms and our instructions," he said. Driving the news: Bengio, a Montreal-based researcher who has long warned about the risks of a technology he helped develop, has raised about $30 million for the nonprofit, dubbed LawZero. LawZero currently has about 15 staffers, Bengio said, "but the goal is to hire many more." Bengio is among those who have called for tougher regulation of AI development and even the breakup of big tech companies. Earlier this year he gave a TED Talk urging greater caution and collaboration. The big picture: There's a growing sense of worry among critics — and even AI practitioners — that safety is taking a back seat as companies and countries race to be first with AI that can best humans in a wide variety of tasks, so-called artificial general intelligence (AGI). Bengio said there is also a high risk in concentrating control of advanced AI in a handful of companies. "You don't want AGI or superintelligence to be in the hands of one person or one company only deciding what to do, or even one government," Bengio said. "So you need very strong checks and balances." Between the lines: Bengio says a large part of the problem is how current systems are trained. During initial training, the systems are taught to mimic humans and then they're honed by seeing which responses people find most appealing. "Both of these give rise to uncontrolled agency," Bengio said. Some early glimmers of this are already appearing, such as Anthropic's latest model which, in a test scenario, sought to blackmail its engineers to avoid shutdown. By contrast, Bengio says he wants to create AI systems that have intellectual distance from humans and act as more of a detached scientist than a personal companion or human agent. "The training principle is completely different, but it can exploit a lot of the recent advances that have happened in machine learning," he said. Yes, but: Bengio told Axios that the $30 million should be enough to fund the basic research effort for about 18 months.
Axios
5 days ago
- Axios
FDA launches agency-wide AI tool
The Food and Drug Administration on Monday is launching an agency-wide generative AI tool aimed at helping scientific reviewers, investigators and others streamline their work, according to details shared with Axios. Why it matters: The model, dubbed "Elsa," is being rolled out weeks ahead of schedule and is designed to help with tasks such as summarizing adverse events to support drug safety profiles, and to generate code for databases. The big picture: FDA said the technology was built in Amazon Web Services' GovCloud environment, which is designed to host sensitive government data. It isn't being trained with proprietary data submitted by drug and device manufacturers, according to a summary shared ahead of the public rollout. FDA did not detail specifically what information the model is being trained on, but said it offers a "secure platform for FDA employees to access internal documents." FDA said it's using the technology to review clinical protocols and speed up scientific evaluations. It soon will be used to identify high-priority targets for inspections, though it did not specify what kind. Zoom out: Public health experts told Axios last month that using more AI within the FDA is a good idea, but questioned how secure the data will be and how quickly the technology can really be integrated into the agency's workflow.
Axios
28-05-2025
- Axios
Beltway bloat could doom Trump's Golden Dome
Intercepting missiles — hitting a bullet with a bullet — is difficult. Overcoming bureaucracy may be even harder. The big picture: President Trump's Golden Dome, a continent's worth of 24/7 overhead defense, will be a jigsaw puzzle of ideas, authorities, personalities, contractors, procurements, production lines, users, fixers, technological leaps and diplomacy. Realizing even the most basic form in three years, as the president and Pentagon promised, will require intense coordination. Getting it done fast means resisting Washington's greatest vice: new offices, task forces, branches, blue-chip studies and advisers. Driving the news: Axios consulted a half-dozen analysts, businesspeople and former defense officials and tuned into some timely think-tank discussions to get a temperature check. Simply put, Golden Dome is polarizing. (And that's without asking what the Chinese or Russians think of it.) The latest: "I think there's been a lot of discussion about the capability ... and there's been little discussion about the organization and the authorities to get stuff done," Tom Karako, an expert at the Center for Strategic and International Studies, said in an interview. "We don't need to re-create the wheel." State of play: Trump this month gave the world its best look yet at Golden (née Iron) Dome during an Oval Office address. He was accompanied by Defense Secretary Pete Hegseth and a handful of lawmakers. The president tapped Gen. Michael Guetlein, the vice chief of space operations, as his lead. Folks Axios spoke with applauded that choice. Trump, who mentioned "super technology," also slapped on a $175 billion price tag. That's low, considering the costs of space-based interceptors at the heart of the concept. He also described Alaska as a key contributor to the vision. A Boeing-led team recently finished building 20 new silos for the homeland missile defense system at Fort Greely, Defense News reported. What they're saying: "There was a rollout, but there was almost no information," Laura Grego, a senior research director at the Union of Concerned Scientists, told Axios. "I think the way most people are starting to use 'Golden Dome' is synonymous with space-based missile defense. But the executive order covered every missile from every adverse area every time," she said. "I can hardly imagine potential adversaries just sitting still, not developing the ways to counter such a system." Yes, but: The defense industry is raring to go. Jordan Blashek, a managing partner at America's Frontier Fund, told Axios "breakthrough technologies have now made something like Golden Dome possible, fulfilling the Reagan administration's vision" for the Strategic Defense Initiative. Trump cited Reagan several times in his Oval Office remarks. Case in point: Apex, a satellite bus maker, is "heavily investing in internal research and development funding for this, as are our partners," CEO Ian Cinnamon said in an inteview. (The company recently announced a $200 million Series C.) Cinnamon foresees different methods for different threats: intercontinental ballistic missiles, hypersonic glide vehicles, fractional orbital bombardment systems. "There are so many pieces ... and they all need to talk," he said. "They all need to listen. They all need to be able to do that within milliseconds."
